CLINICAL_TRIALS
trial_result
· 2022-02-08
Clinical Trial Update: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial updates comparing LY900014 to insulin lispro in adults with type 2 diabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2022-02-08